Literature DB >> 28163790

Hypertrophy changes 3D shape of hiPSC-cardiomyocytes: Implications for cellular maturation in regenerative medicine.

Cassady E Rupert1, Heidi H Chang2, Kareen L K Coulombe3.   

Abstract

Advances in the use of human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes for heart regeneration and in vitro disease models demand a greater understanding of how these cells grow and mature in 3-dimensional space. In this study, we developed an analysis methodology of single cardiomyocytes plated on 2D surfaces to assess their 3D myofilament volume and its z-height distribution, or shape, upon hypertrophic stimulation via phenylephrine (PE) treatment or long-term culture ("aging"). Cardiomyocytes were fixed and labeled with α-actinin for confocal microscopy imaging to obtain z-stacks for 3D myofilament volume analysis. In primary neonatal rat ventricular myocytes (NRVMs), area increased 72% with PE, while volume increased 31%. In hiPSC-cardiomyocytes, area increased 70% with PE and 4-fold with aging; however, volume increased significantly only with aging by 2.3-fold. Analysis of z-height myofilament volume distribution in hiPSC-cardiomyocytes revealed a shift from a fairly uniform distribution in control cells to a basally located volume in a more flat and spread morphology with PE and even more so with aging, a shape that was akin to all NRVMs analyzed. These results suggest that 2D area is not a sufficient measure of hiPSC-cardiomyocyte growth and maturation, and that changes in 3D volume and its distribution are essential for understanding hiPSC-cardiomyocyte biology for disease modeling and regenerative medicine applications.

Entities:  

Keywords:  Confocal microscopy; aging; image analysis; myofilament volume; phenylephrine

Year:  2016        PMID: 28163790      PMCID: PMC5287696          DOI: 10.1007/s12195-016-0462-7

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   2.321


  32 in total

Review 1.  Cardiomyocyte cell cycle regulation.

Authors:  Kishore B S Pasumarthi; Loren J Field
Journal:  Circ Res       Date:  2002-05-31       Impact factor: 17.367

2.  Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.

Authors:  Jacqueline S Wendel; Lei Ye; Ran Tao; Jianyi Zhang; Jianhua Zhang; Timothy J Kamp; Robert T Tranquillo
Journal:  Stem Cells Transl Med       Date:  2015-09-14       Impact factor: 6.940

Review 3.  Regulation of the cardiomyocyte population in the developing heart.

Authors:  Kent Thornburg; Sonnet Jonker; Perrie O'Tierney; Natasha Chattergoon; Samantha Louey; Job Faber; George Giraud
Journal:  Prog Biophys Mol Biol       Date:  2010-12-13       Impact factor: 3.667

4.  Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy.

Authors:  Wei Zhang; Thomas Anger; Jialin Su; Jianming Hao; Xiaomei Xu; Ming Zhu; Agnieszka Gach; Lei Cui; Ronglih Liao; Ulrike Mende
Journal:  J Biol Chem       Date:  2005-12-26       Impact factor: 5.157

5.  Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.

Authors:  Xiaojun Lian; Jianhua Zhang; Samira M Azarin; Kexian Zhu; Laurie B Hazeltine; Xiaoping Bao; Cheston Hsiao; Timothy J Kamp; Sean P Palecek
Journal:  Nat Protoc       Date:  2012-12-20       Impact factor: 13.491

6.  Measuring single cell mass, volume, and density with dual suspended microchannel resonators.

Authors:  Andrea K Bryan; Vivian C Hecht; Wenjiang Shen; Kristofor Payer; William H Grover; Scott R Manalis
Journal:  Lab Chip       Date:  2014-02-07       Impact factor: 6.799

7.  Morphometric analysis of cardiac hypertrophy during development, maturation, and senescence in spontaneously hypertensive rats.

Authors:  G L Engelmann; J C Vitullo; R G Gerrity
Journal:  Circ Res       Date:  1987-04       Impact factor: 17.367

8.  Aberrant α-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells.

Authors:  Gabor Földes; Elena Matsa; János Kriston-Vizi; Thomas Leja; Stefan Amisten; Ljudmila Kolker; Thusharika Kodagoda; Nazanin F Dolatshad; Maxime Mioulane; Karine Vauchez; Tamás Arányi; Robin Ketteler; Michael D Schneider; Chris Denning; Sian E Harding
Journal:  Stem Cell Reports       Date:  2014-10-11       Impact factor: 7.765

9.  Membrane-myofibril cross-talk in myofibrillogenesis and in muscular dystrophy pathogenesis: lessons from the zebrafish.

Authors:  Maide Ö Raeker; Jordan A Shavit; James J Dowling; Daniel E Michele; Mark W Russell
Journal:  Front Physiol       Date:  2014-01-28       Impact factor: 4.566

10.  Chemically defined generation of human cardiomyocytes.

Authors:  Paul W Burridge; Elena Matsa; Praveen Shukla; Ziliang C Lin; Jared M Churko; Antje D Ebert; Feng Lan; Sebastian Diecke; Bruno Huber; Nicholas M Mordwinkin; Jordan R Plews; Oscar J Abilez; Bianxiao Cui; Joseph D Gold; Joseph C Wu
Journal:  Nat Methods       Date:  2014-06-15       Impact factor: 28.547

View more
  8 in total

1.  Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Man Liu; Guangbin Shi; Anyu Zhou; Cassady E Rupert; Kareen L K Coulombe; Samuel C Dudley
Journal:  J Mol Cell Cardiol       Date:  2018-02-21       Impact factor: 5.000

2.  IGF1 and NRG1 Enhance Proliferation, Metabolic Maturity, and the Force-Frequency Response in hESC-Derived Engineered Cardiac Tissues.

Authors:  Cassady E Rupert; Kareen L K Coulombe
Journal:  Stem Cells Int       Date:  2017-08-29       Impact factor: 5.443

3.  Human Cardiac Fibroblast Number and Activation State Modulate Electromechanical Function of hiPSC-Cardiomyocytes in Engineered Myocardium.

Authors:  Cassady E Rupert; Tae Yun Kim; Bum-Rak Choi; Kareen L K Coulombe
Journal:  Stem Cells Int       Date:  2020-07-16       Impact factor: 5.443

4.  C-MORE: A high-content single-cell morphology recognition methodology for liquid biopsies toward personalized cardiovascular medicine.

Authors:  Jennifer Furkel; Maximilian Knoll; Shabana Din; Nicolai V Bogert; Timon Seeger; Norbert Frey; Amir Abdollahi; Hugo A Katus; Mathias H Konstandin
Journal:  Cell Rep Med       Date:  2021-11-03

5.  Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes.

Authors:  Ekaterina Ovchinnikova; Martijn Hoes; Kirill Ustyantsev; Nils Bomer; Tristan V de Jong; Henny van der Mei; Eugene Berezikov; Peter van der Meer
Journal:  Stem Cell Reports       Date:  2018-02-15       Impact factor: 7.765

6.  Practical adoption of state-of-the-art hiPSC-cardiomyocyte differentiation techniques.

Authors:  Cassady E Rupert; Chinedu Irofuala; Kareen L K Coulombe
Journal:  PLoS One       Date:  2020-03-10       Impact factor: 3.240

Review 7.  Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening.

Authors:  Paz Ovics; Danielle Regev; Polina Baskin; Mor Davidor; Yuval Shemer; Shunit Neeman; Yael Ben-Haim; Ofer Binah
Journal:  Int J Mol Sci       Date:  2020-10-03       Impact factor: 5.923

8.  Architected fibrous scaffolds for engineering anisotropic tissues.

Authors:  James Alexander Reid; Kiera D Dwyer; Phillip R Schmitt; Arvin H Soepriatna; Kareen Lk Coulombe; Anthony Callanan
Journal:  Biofabrication       Date:  2021-07-27       Impact factor: 9.954

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.